Gian Life Care
Ticker > Company >

Gian Life Care share price

Gian Life Care Ltd.

BSE: 542918 SECTOR: Hospital & Healthcare Services  15k   61   3

18.09
+0.42 (2.38%)
BSE: Today, 04:01 PM

Price Summary

Today's High

₹ 18.1

Today's Low

₹ 16.74

52 Week High

₹ 29

52 Week Low

₹ 12.06

FinStar is Suspended!

FinStar can not be assigned to this company due to its dicey outlook and insufficient data. We will update the FinStar for this company as soon as the data is updated from its end.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 18.71 Cr.

Enterprise Value

₹ 16.9 Cr.

No. of Shares

1.03 Cr.

P/E

4.59

P/B

0.94

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  19.21

CASH

₹ 5.97 Cr.

DEBT

₹ 4.17 Cr.

Promoter Holding

31.99 %

EPS (TTM)

₹  3.94

Sales Growth

10.02%

ROE

24.59 %

ROCE

29.24%

Profit Growth

241.62 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year10.02%
3 Year7.86%
5 Year88.02%

Profit Growth

1 Year241.62%
3 Year28.65%
5 Year111.96%

ROE%

1 Year24.59%
3 Year23.37%
5 Year24.5%

ROCE %

1 Year29.24%
3 Year31.62%
5 Year34.65%

Debt/Equity

0.2124

Price to Cash Flow

24.87

Interest Cover Ratio

13.5014

CFO/PAT (5 Yr. Avg.)

1.01239494311518

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 31.99 62.27
Jun 2024 32.82 0.00
Mar 2024 48.47 26.53
Dec 2023 51.73 0.00
Sep 2023 53.10 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company has been maintaining healthy ROE of 23.367469310389% over the past 3 years.
  • Company has been maintaining healthy ROCE of 31.6226129876966% over the past 3 years.
  • Company has a healthy Interest coverage ratio of 13.5014.
  • The Company has been maintaining an effective average operating margins of 34.3022303345062% in the last 5 years.
  • Company’s PEG ratio is 0.0189960639347171.
  • The company has an efficient Cash Conversion Cycle of -478.2375 days.
  • The company has a good cash flow management; CFO/PAT stands at 1.01239494311518.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 7.73993196385892.

 Limitations

  • The company has shown a poor revenue growth of 7.86173384300266% for the Past 3 years.
  • Promoter pledging has increased from 0% to 62.27% in 1 quarter.
  • Promoter pledging is high as 62.27%.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Net Sales 2.3 3.79 4.6 1.98 1.95
Total Expenditure 1.97 1.55 1.5 1.76 1.72
Operating Profit 0.33 2.24 3.1 0.22 0.22
Other Income 0.15 0.16 0.18 0.17 0.16
Interest 0.11 0.11 0.11 0.11 0.1
Depreciation 0.13 0.13 0.07 0.12 0.12
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.24 2.16 3.11 0.17 0.17
Tax 0.04 0.53 0.91 0.06 0.03
Profit After Tax 0.21 1.63 2.2 0.11 0.14
Adjusted EPS (Rs) 0.2 1.57 2.13 0.1 0.14

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 7.65 10.46 15.93 11.92 13.12
Total Expenditure 5.33 6.98 9 9.88 6.91
Operating Profit 2.32 3.48 6.93 2.04 6.21
Other Income 0.1 0.29 0.51 0.69 0.64
Interest 0.61 0.73 1.25 0.45 0.47
Depreciation 0.26 0.29 0.33 0.5 0.46
Exceptional Items 0 0 0 0 0
Profit Before Tax 1.56 2.75 5.85 1.79 5.91
Tax 0.43 0.74 1.48 0.53 1.62
Net Profit 1.13 2.02 4.37 1.26 4.3
Adjusted EPS (Rs.) 1.09 1.95 4.23 1.22 4.15

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 4.7 4.7 10.34 10.34 10.34
Total Reserves 2.94 4.96 3.69 4.97 9.27
Borrowings 0.75 0.62 1.87 1.65 1.8
Other N/C liabilities 0.17 0.17 0.26 0.7 1.04
Current liabilities 3.81 5.03 6.9 10.74 9.62
Total Liabilities 12.37 15.48 23.06 28.4 32.07
Assets
Net Block 2.84 2.99 3.5 4.62 4.47
Capital WIP 0 0 0.12 0.14 0.14
Intangible WIP 0 0 0 0 0
Investments 0 0 0.11 0.11 0.11
Loans & Advances 5.44 6.46 8.73 11.76 13.76
Other N/C Assets 0 0 0.29 0.3 0.41
Current Assets 4.09 6.03 10.31 11.48 13.18
Total Assets 12.37 15.48 23.06 28.4 32.07
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 1.56 2.75 5.85 1.79 5.91
Adjustment 0.6 0.42 1.93 0.26 0.28
Changes in Assets & Liabilities -0.42 -0.01 -1.32 0.3 -5.42
Tax Paid -0.23 -0.3 -0.67 -0.02 -0.02
Operating Cash Flow 1.51 2.87 5.79 2.32 0.75
Investing Cash Flow -3.96 -1.1 -4.23 -0.94 0.33
Financing Cash Flow 2.55 -0.39 0.67 -0.37 -0.86
Net Cash Flow 0.1 1.38 2.23 1.01 0.22

Corporate Actions

Investors Details

PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
promoters 53.10 51.73 48.47 32.82 31.99
arun kumar gupta 50.01 48.64 45.37 29.73 28.89
avani gupta 2.24 2.24 2.24 2.24 2.24
devang agarwal 0.42 0.42 0.42 0.42 0.42
rashika agarwal 0.42 0.42 0.42 0.42 0.42
PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
investors 46.90 48.27 51.53 67.18 68.01
n mohan neela judith - - - - 2.77
prashant prithviraj jain 1.02 1.07 1.11 1.11 1.11
rahul govind binnani - - - - 1.06
shield multistate coopera... 4.59 4.59 7.14 6.55 6.49
sundiip devaadigaa - - - 9.67 3.69
tejesh hasmukh shah - - - - 3.64
nathabhai bhikhabhai pate... - - 1.07 - -
rajesh mahohar makode - - 1.06 - -
digonta bordoloi 1.88 1.89 - - -

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Gian Life Care Stock Price Analysis and Quick Research Report. Is Gian Life Care an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Gian Life Care and its performance over the period of time. Gian Life Care stock price today is Rs 18.09.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Gian Life Care cash from the operating activity was Rs 0.7523 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Gian Life Care has a Debt to Equity ratio of 0.2124 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Gian Life Care , the EPS growth was 241.6153 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Gian Life Care has OPM of 47.2972148965686 % which is a good sign for profitability.
     
  • ROE: Gian Life Care have a healthy ROE of 24.5947 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Gian Life Care is Rs 18.09. One can use valuation calculators of ticker to know if Gian Life Care share price is undervalued or overvalued.
Last Updated on:
Brief about Gian Life Care
X